In drug-refractory IBS, group CBT with interoceptive exposure improved symptoms and QoL at 13 wk.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 35914262.
- Also identified by DOI 10.7326/J22-0054.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Kikuchi S, Oe Y, Ito Y, et al. <b>Group cognitive-behavioral therapy with interoceptive exposure for drug-refractory irritable bowel syndrome: a randomized controlled trial.</b> Am J Gastroenterol. 2022;117:668-77. 35103022.
Medical subject headings
- Cognitive Behavioral Therapy
- Irritable Bowel Syndrome